Analysts Set Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Target Price at $12.13

Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) have earned an average recommendation of "Buy" from the six ratings firms that are currently covering the stock, MarketBeat.com reports. Four investment analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $12.13.

BIOX has been the subject of a number of recent analyst reports. Oppenheimer dropped their price target on Bioceres Crop Solutions from $16.00 to $13.00 and set an "outperform" rating for the company in a report on Monday, October 21st. Roth Mkm dropped their price target on Bioceres Crop Solutions from $15.00 to $13.00 and set a "buy" rating for the company in a report on Wednesday, September 11th. Canaccord Genuity Group dropped their target price on Bioceres Crop Solutions from $10.00 to $9.50 and set a "buy" rating for the company in a research report on Wednesday, November 13th. Finally, Lake Street Capital lowered their price target on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a "buy" rating for the company in a research report on Wednesday, September 11th.

Bioceres Crop Solutions Price Performance

BIOX stock traded up $0.46 during midday trading on Monday, reaching $6.59. 418,141 shares of the company's stock traded hands, compared to its average volume of 93,360. The company has a 50-day simple moving average of $7.20 and a two-hundred day simple moving average of $9.47. Bioceres Crop Solutions has a 1-year low of $5.71 and a 1-year high of $14.05. The company has a market cap of $414.18 million, a price-to-earnings ratio of 329.66 and a beta of 0.49. The company has a quick ratio of 0.87, a current ratio of 1.27 and a debt-to-equity ratio of 0.37.

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last released its quarterly earnings results on Monday, November 11th. The company reported ($0.09) earnings per share for the quarter, missing analysts' consensus estimates of $0.02 by ($0.11). Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. The business had revenue of $92.60 million for the quarter, compared to analyst estimates of $117.15 million. During the same period in the prior year, the business earned ($0.07) earnings per share. On average, analysts anticipate that Bioceres Crop Solutions will post 0.12 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the company. Stifel Financial Corp grew its holdings in Bioceres Crop Solutions by 33.4% during the third quarter. Stifel Financial Corp now owns 40,790 shares of the company's stock valued at $321,000 after purchasing an additional 10,224 shares during the period. Fourth Sail Capital LP grew its holdings in Bioceres Crop Solutions by 61.6% during the third quarter. Fourth Sail Capital LP now owns 3,171,102 shares of the company's stock valued at $24,957,000 after purchasing an additional 1,209,277 shares during the period. Long Focus Capital Management LLC grew its holdings in Bioceres Crop Solutions by 19.9% during the second quarter. Long Focus Capital Management LLC now owns 280,547 shares of the company's stock valued at $3,145,000 after purchasing an additional 46,647 shares during the period. Dimensional Fund Advisors LP grew its holdings in Bioceres Crop Solutions by 9.5% during the second quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company's stock valued at $688,000 after purchasing an additional 5,341 shares during the period. Finally, Ping Capital Management Inc. acquired a new position in Bioceres Crop Solutions during the second quarter valued at approximately $448,000. Institutional investors and hedge funds own 17.68% of the company's stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.